Freshfields advised Novartis on its exclusive license agreement with Arvinas for a potential first-in-class prostate cancer treatment. Novartis, a global healthcare company, has entered into an...
You must be a Standard 1 Year member to access this content.
Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
You must be a Standard 1 Year member to access this content.
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
You must be a Standard 1 Year member to access this content.
Freshfields advised Sairopa on the deal. Sairopa, a clinical-stage company that develops novel treatments for cancer by modulating the patient’s immune system, signed a collaboration and...
You must be a Standard 1 Year member to access this content.
Freshfields Advised Moderna on the deal. Moderna completed its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility at...
You must be a Standard 1 Year member to access this content.
